AzTrials
AzTrials

White Spot Lesions [Initial Caries] on Smooth Surface of ToothNCT07845110

EFFICACY OF BIOMIN FLUORIDE VERSUS SODIUM FLUORIDE VARNISHES, WITH AND WITHOUT DIODE LASER ON WHITE SPOT LESIONS REMINERALIZATION IN PRIMARY TEETH.

A study testing BioMin® fluoride varnish: 5% NaF varnish incorporating bioactive glass (calcium/phosphate releasing)., (BioMin® + Diode Laser) and (Duraphat varnish + Diode laser) in people with White Spot Lesions [Initial Caries] on Smooth Surface of Tooth, run by Yassmin Mohamed at 2 sites in Egypt.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this randomized controlled clinical trial is to assess and compare the remineralizing effect of Biomin fluoride varnish and conventional 5% sodium fluoride varnish (Duraphat), with and without adjunctive low-level diode laser irradiation, in preschool children with active white spot lesions in primary… Read more about this study

Who is it for?
Ages 3 to 6 years
What is being tested?
BioMin® fluoride varnish: 5% NaF varnish incorporating bioactive glass (calcium/phosphate releasing)., (BioMin® + Diode Laser) and (Duraphat varnish + Diode laser)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
80 participants
Where
2 sitesEgypt
Study dates
1 Oct 2026to 1 Apr 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 3 to 6 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • • Healthy Children aged 3-6 years old.
  • Patients ranking definitely positive or positive on Frankel scale
  • The Presence of at least one active non-cavitated white spot lesion (ICDAS code 1 or 2) on the facial surface of primary teeth .
  • Completion of an informed consent by the guardian to participate in the study

Who cannot join

  • History of systemic disease or medication affecting enamel development
  • Teeth with cavitated lesions (ICDAS ≥ 3)
  • Previous professional fluoride treatment or laser therapy in the last 3 months

Trial locations and contacts

2 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Yassmin Mohamed Hassan, BDs contact

+20 01005364640

yassmin.moh150@gmail.com

Egypt2 sites, 2 recruiting
  • Faculty of Dentistry, Alexandria university, Egypt

    Alexandria, Alexandria Governorate, 21519

    Recruiting
  • Faculty of Dentistry, Alexandria university, Egypt

    Alexandria, Alexandria Governorate, 21519

    Yassmin Mohamed Hassan, BDs, +20 1005364640, yassmin.moh150@gmail.com

    Recruiting

Other trials in Egypt

About this study

Official title: EFFICACY OF BIOMIN FLUORIDE VERSUS SODIUM FLUORIDE VARNISHES, WITH AND WITHOUT DIODE LASER ON WHITE SPOT LESIONS REMINERALIZATION IN PRIMARY TEETH (A RANDOMIZED CONTROLLED CLINICAL TRIAL)

The goal of this randomized controlled clinical trial is to assess and compare the remineralizing effect of Biomin fluoride varnish and conventional 5% sodium fluoride varnish (Duraphat), with and without adjunctive low-level diode laser irradiation, in preschool children with active white spot lesions in primary anterior teeth. The study will include healthy children aged 3-6 years with at least one active, non-cavitated white spot lesion (ICDAS-II score 1 or 2). The study will be conducted at the Faculty of Dentistry, Alexandria University, with a total of 80 lesions randomly allocated to four parallel groups.

The main questions it aims to answer are:

Read more

Does Biomin fluoride varnish produce a different remineralizing effect compared with conventional 5% sodium fluoride varnish (Duraphat) after 6 months? Does adding 980-nm low-level diode laser irradiation to Biomin fluoride varnish or Duraphat improve the remineralization of white spot lesions compared with the corresponding varnish alone? Do the different treatments result in changes in lesion severity and activity, as assessed by ICDAS-II and DIAGNOdent readings? Do the treatments reduce the surface area of white spot lesions after 6 months?

Researchers will compare four treatment groups to assess differences in remineralization:

Group I (n=20): Biomin fluoride varnish (5% sodium fluoride incorporating bioactive glass).

Group II (n=20): Biomin fluoride varnish combined with low-level diode laser. Group III (n=20): Duraphat 5% sodium fluoride varnish combined with low-level diode laser.

Group IV (n=20): Duraphat 5% sodium fluoride varnish alone (control group).

Participants will:

Undergo baseline assessment of their white spot lesions using ICDAS-II visual-tactile examination, DIAGNOdent laser fluorescence, and standardized photographic assessment.

Receive the randomly assigned fluoride varnish treatment, with diode laser irradiation applied to Groups II and III using a 980-nm diode laser.

Return for follow-up assessments at 1, 3, and 6 months. At 3 months, the assigned varnish and laser treatment will be reapplied according to the group.

Have lesion severity and activity assessed using ICDAS-II and changes in mineralization assessed through DIAGNOdent readings. At 6 months, standardized photographs will also be used to evaluate changes in lesion surface area.

Follow post-treatment instructions, including avoiding fluoride-containing products on the day of varnish application and avoiding eating and drinking for at least 4 hours.

The primary outcome is caries arrest/remineralization assessed through changes in lesion severity and activity using ICDAS-II and changes in mean DIAGNOdent readings at 1, 3, and 6 months. The secondary outcome is the change in white spot lesion surface area measured by standardized photographic assessment at 6 months.

Read the detailed description

White spot lesions (WSLs) are early manifestations of enamel caries characterized by subsurface mineral loss while the enamel surface remains clinically intact. In primary teeth, early lesions may progress rapidly, making non-invasive remineralization an important approach for preserving tooth structure and preventing progression to cavitation. Fluoride varnish is widely used for the management of early enamel lesions; however, conventional fluoride varnishes may have limited retention on the tooth surface and may primarily promote remineralization near the enamel surface.

Bioactive glass-containing materials have been developed as an alternative or adjunctive remineralization strategy. Biomin fluoride varnish incorporates bioactive glass capable of releasing calcium, phosphate, and fluoride ions in the oral environment. According to the protocol, the sustained release of these ions may promote formation of fluorapatite and potentially provide deeper and longer-lasting remineralization of early enamel lesions.

Low-level diode laser irradiation has also been proposed as an adjunct to topical fluoride treatment. The protocol describes laser irradiation as potentially increasing enamel resistance to acid attack and enhancing fluoride uptake. However, previous findings cited in the protocol are not consistent: some studies have suggested a synergistic effect between laser irradiation and remineralizing agents, whereas other studies have not demonstrated an additional benefit when laser treatment is combined with fluoride or Biomin products. The protocol therefore identifies a need for clinical evaluation of these approaches in primary teeth.

This study is designed as a four-arm, parallel, randomized controlled clinical trial. Participants meeting the study criteria will be randomly allocated to receive one of the study treatment approaches. The allocation will be computer-generated with an equal allocation ratio, and treatment assignment will be concealed until the intervention. The outcome assessor will remain blinded to treatment allocation.

The study will evaluate the clinical and quantitative changes occurring in active, non-cavitated white spot lesions during a 6-month follow-up period. Lesion status will be monitored using clinical assessment with the International Caries Detection and Assessment System (ICDAS-II) and quantitative assessment using laser-induced fluorescence with the DIAGNOdent™ pen. These assessments will allow changes in lesion severity, activity, and fluorescence readings to be followed over time. Standardized photographic records will additionally be used at the end of follow-up to evaluate changes in the proportional surface area of the lesions.

Before treatment, eligible lesions will undergo baseline assessment following cleaning and standardized examination procedures. The investigator will be trained and calibrated in the use of ICDAS-II and DIAGNOdent™. Lesion activity will be assessed clinically, while DIAGNOdent measurements will provide numerical readings related to enamel demineralization. Standardized photographs will be obtained under controlled conditions to permit subsequent comparison of lesion size.

The assigned varnish will be applied according to the manufacturer's instructions. For participants allocated to the laser groups, the diode laser will be applied following varnish application using the parameters specified in the study protocol. Participants will receive post-treatment instructions concerning fluoride-containing products and eating and drinking following varnish application. At the 3-month visit, the assigned treatment will be reapplied, followed by the same post-application instructions.

Follow-up examinations will take place at predetermined intervals during the 6-month study period. Clinical and DIAGNOdent assessments will be repeated during follow-up, while standardized photographic assessment will be performed at the final visit. All follow-up assessments will be conducted by the same calibrated examiner, who will remain unaware of the treatment allocation.

The study is intended to determine whether the incorporation of bioactive glass into a fluoride varnish and/or the addition of low-level diode laser irradiation is associated with greater improvement in early white spot lesions than conventional fluoride varnish alone. The findings are expected to provide clinical evidence regarding the use of these non-invasive approaches for the management of early carious lesions in primary teeth.

The protocol states that written informed consent will be obtained from the parent or guardian before participation. The study activities will be conducted in accordance with the ethical requirements of the Faculty of Dentistry, Alexandria University, and the Declaration of Helsinki. Participants and their guardians will also receive oral hygiene and dietary instructions as part of the study procedures. The protocol reports that no study-related hazards or side effects are anticipated.

Being tested
BioMin® fluoride varnish: 5% NaF varnish incorporating bioactive glass (calcium/phosphate releasing)., (BioMin® + Diode Laser), (Duraphat varnish + Diode laser), Duraphat varnish (5% sodium fluoride varnish)
Keywords
Remineralization Primary Anterior Teeth Fluoride Varnish BioMin Fluoride Diode Laser

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • BioMin® fluoride varnish: 5% NaF varnish incorporating bioactive glass (calcium/phosphate releasing).Other

    will be applied according to the manufacturer's instructions as follows

    1. Excess plaque should be removed
    2. Teeth should be isolated and gently dried
    3. BioMin fluoride varnish will be applied using a disposable microbrush in thin layer and allowed to set
  • (BioMin® + Diode Laser)Other

    • After application of BioMin® fluoride varnish as described above, the tooth surface will be irradiated using a diode laser Wavelength: 980 nm.
    • Operating Mode: Continuous wave.
    • Fiber tip:320 µm.
    • Radiant Energy :15 J.
    • Mode: Non-contact mode.
    • Duration: 30 seconds.
    • Laser safety eyewear: OD ≥ 5 at 980 nm for operator, patient, and assistant.
  • (Duraphat varnish + Diode laser)Other

    After application of DURAPHAT fluoride varnish as described above, the tooth surface will be irradiated using a diode laser with the following parameters(16):

    • Wavelength: 980 nm.
    • Operating Mode: Continuous wave.
    • Fiber tip:320 µm.
    • Mode: Non-contact mode.
    • Duration: 30 seconds.
    • Radiant Energy: 15 J.
    • Laser safety eyewear: OD ≥ 5 at 980 nm for operator, patient, and assistant.
  • Duraphat varnish (5% sodium fluoride varnish)Other

    will be applied to all white spot lesions according to the manufacturers' instructions as follows:

    1. Excess plaque should be removed
    2. Teeth should be isolated and gently dried
    3. Duraphat can be applied using a brush in a thin layer on the affected areas and allowed to set.
Study groups in NCT07845110
Study groupRoleWhat they receive
Test group 1Experimental• Group I (Test Group I): BioMin® fluoride varnish: 5% NaF varnish incorporating bioactive glass (calcium/phosphate releasing). will be applied according to the manufacturer's instructions as follows 1. Excess plaque should be removed 2. Teeth should be isolated and gently dried 3. BioMin fluoride varnish will be applied using a disposable microbrush in thin layer and allowed to set
Receives: Other: BioMin® fluoride varnish: 5% NaF varnish incorporating bioactive glass (calcium/phosphate releasing).
Test group 2Experimental(BioMin® + Diode Laser): After application of BioMin® fluoride varnish as described above, the tooth surface will be irradiated using a diode laser with the following parameters: * Wavelength: 980 nm. * Operating Mode: Continuous wave. * Fiber tip:320 µm. * Radiant Energy :15 J. * Mode: Non-contact mode. * Duration: 30 seconds. * Laser safety eyewear: OD ≥ 5 at 980 nm for operator, patient, and assistant.
Receives: Other: (BioMin® + Diode Laser)
Test group 3Experimental(Duraphat varnish + Diode laser ): After application of DURAPHAT fluoride varnish as described above, the tooth surface will be irradiated using a diode laser with the following parameters: * Wavelength: 980 nm. * Operating Mode: Continuous wave. * Fiber tip:320 µm. * Mode: Non-contact mode. * Duration: 30 seconds. * Radiant Energy: 15 J. * Laser safety eyewear: OD ≥ 5 at 980 nm for operator, patient, and assistant.
Receives: Other: (Duraphat varnish + Diode laser)
Control groupActive comparatorDuraphat varnish (5% sodium fluoride varnish) will be applied to all white spot lesions according to the manufacturers' instructions as follows: 1. Excess plaque should be removed 2. Teeth should be isolated and gently dried 3. Duraphat can be applied using a brush in a thin layer on the affected areas and allowed to set.
Receives: Other: Duraphat varnish (5% sodium fluoride varnish)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The primary outcome of this study will be to assess caries arrest status by assessing lesion severity and activity using (ICDAS-II) criteria and the change in mean DIAGNOdentTM readings at 1, 3 and 6 months follow up .

    The primary outcome of this study will be to assess caries arrest status by assessing lesion severity and activity using (ICDAS-II) criteria and the change in mean DIAGNOdentTM readings at 1, 3 and 6 months follow up .

    Measured: 6 months

Secondary outcomes (1)
  1. • Assessment of the change in lesion surface area using standardized photographic assessment at 6 months follow up.

    • Assessment of the change in lesion surface area using standardized photographic assessment at 6 months follow up.

    Measured: 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Sep 2026
  2. Study start1 Oct 2026 (estimated)
  3. Primary completion1 Apr 2027 (estimated)
  4. Study completion1 Apr 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
80 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07845110
Sponsor's protocol ID
1227-01L2026
Status last verified
Sep 2026
First submitted
22 Sep 2026
Last updated
30 Sep 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing BioMin® fluoride varnish: 5% NaF varnish incorporating bioactive glass (calcium/phosphate releasing)., (BioMin® + Diode Laser) and (Duraphat varnish + Diode laser) in people with White Spot Lesions [Initial Caries] on Smooth Surface of Tooth, run by Yassmin Mohamed at 2 sites in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 30 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Yassmin Mohamed Hassan, BDs (+20 01005364640, yassmin.moh150@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The primary outcome of this study will be to assess caries arrest status by assessing lesion severity and activity using (ICDAS-II) criteria and the change in mean DIAGNOdentTM readings at 1, 3 and 6 months follow up . (time frame: 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in